WVE

10.27

5.00% -0.54

Dopo l'orario di chiusura: 10.47 0.20 +1.95%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$10.81

Aprire:

$10.8

Volume 24 ore:

777.82K

Relative Volume:

0.83

Capitalizzazione di mercato:

$1.58B

Reddito:

$53.61M

Utile/perdita netta:

$-142.52M

Rapporto P/E:

-9.2523

EPS:

-1.11

Flusso di cassa netto:

$-141.83M

1 W Prestazione:

+0.88%

1M Prestazione:

-4.91%

6M Prestazione:

+75.26%

1 anno Prestazione:

+50.26%

Intervallo 1D:

$10.21

$10.89

Intervallo di 1 settimana:

$8.57

$10.96

Portata 52W:

$4.25

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1169)

Industria

Biotechnology (679)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

288

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2025-03-04

Ultimi documenti SEC

WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	10.27	1.58B	53.61M	-142.52M	-141.83M	-1.11
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

Mar 12, 2025

Wave Life Sciences’ SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com

Mar 12, 2025

Mar 10, 2025

Mizuho maintains WAVE Life Sciences Outperform rating - Investing.com India

Mar 10, 2025

Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 10, 2025

Mar 09, 2025

Paul Bolno Sells 169,025 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) Stock - Defense World

Mar 09, 2025

Mar 08, 2025

HC Wainwright Cuts Earnings Estimates for Wave Life Sciences - Defense World

Mar 08, 2025

Wave Life Sciences (NASDAQ:WVE) Rating Increased to Hold at StockNews.com - Defense World

Mar 08, 2025

Q1 EPS Forecast for Wave Life Sciences Decreased by Analyst - Defense World

Mar 08, 2025

Mar 07, 2025

Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million - Investing.com

Mar 07, 2025

Commit To Purchase Wave Life Sciences At $7.50, Earn 25.6% Annualized Using Options - Nasdaq

Mar 07, 2025

Wave Life Sciences (NASDAQ:WVE) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 07, 2025

Analysts Set Expectations for WVE Q1 Earnings - Defense World

Mar 07, 2025

Mar 06, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com India

Mar 06, 2025

Mar 05, 2025

Wave Life Sciences’ Earnings Call Highlights Progress and Challenges - TipRanks

Mar 05, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025

Truist maintains Buy rating on WAVE Life Sciences stock, $36 target By Investing.com - Investing.com South Africa

Mar 05, 2025

RBC Trims Price Target on Wave Life Sciences to $14 From $15, Keeps Sector Perform, Speculative Risk - Marketscreener.com

Mar 05, 2025

Rhumbline Advisers Buys 17,316 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Mar 05, 2025